|
⚲
|
| Keyboard |
| Myla Lai-Goldman | |
|---|---|
| Firm | |
| Address | c/o Genecentric Therapeutics, Inc 100 Capitola Dr, Ste 275 Durham, NC 27713 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Genecentric Therapeutics Inc | 021-549421 | Director | 2.0 M of 5.0 M |
||
| Genecentric Therapeutics Inc | 021-459294 | Director | 2.5 M of 3.5 M |
||
| Genecentric Therapeutics Inc | 021-416162 | Executive Officer | 4.5 M of 7.5 M |
||
| Genecentric Therapeutics Inc | 021-386126 | Executive Officer | 1.2 M of 1.2 M |
||
| Genecentric Diagnostics Inc | 021-277741 | Executive Officer | 6.1 M of 8.6 M |
||
| Sequenom Inc | 021-242128 | Director | 85.0 M of 85.0 M |
||
| Genecentric Diagnostics Inc | 021-198924 | Executive Officer | 5.0 M of 5.0 M |
||
| Sequenom Inc | 021-184494 | Director | 130.0 M of 130.0 M |
||
| Genecentric Diagnostics Inc | 021-165975 | Executive Officer | 0.2 M of 0.2 M |
||
| Cancerguide Diagnostics Inc | 021-138168 | Executive Officer | 2.7 M of 10.5 M |
||